Records 1 - 4 (of 4 Records)
|Query Trace: Carcinoma in Situ and AKT1[original query]|
| PIK3CA mutations rarely demonstrate genotypic intratumoral heterogeneity and are selected for in breast cancer progression.
Breast cancer research and treatment 2011 Sep 129 (2): 635-43.
Kalinsky Kevin, Heguy Adriana, Bhanot Umeshkumar K, Patil Sujata, Moynahan Mary Ell
| Phosphatidylinositol-3-kinase pathway mutations are common in breast columnar cell lesions.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2012 Jul 25 (7): 930-7.
Troxell Megan L, Brunner Alayne L, Neff Tanaya, Warrick Andrea, Beadling Carol, Montgomery Kelli, Zhu Shirley, Corless Christopher L, West Robert
| Frequent phosphatidylinositol-3-kinase mutations in proliferative breast lesions.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2014 May 27 (5): 740-50.
Ang Daphne C, Warrick Andrea L, Shilling Amy, Beadling Carol, Corless Christopher L, Troxell Megan
| Genomic differences between pure ductal carcinoma in situ and synchronous ductal carcinoma in situ with invasive breast cancer.
Oncotarget 2015 Apr 6 (10): 7597-607.
Kim Shinn Young, Jung Seung-Hyun, Kim Min Sung, Baek In-Pyo, Lee Sung Hak, Kim Tae-Min, Chung Yeun-Jun, Lee Sug Hyu